| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |